Title: Revolutionary Tool Identifies Best Glucose-Lowering Drugs for Type 2 Diabetes
London: Despite the ongoing struggle of type 2 diabetes patients to find the most effective medication, a groundbreaking tool has been developed to address this long-standing challenge. A team from the University of Exeter, in collaboration with the UK’s National Institute for Health and Care Research (NIHR), has introduced an innovative digital tool to identify the most effective glucose-lowering drugs for people with type 2 diabetes.
Study Reveals Significant Gaps in Treatment
A study published in The Lancet revealed that only 18% of type 2 diabetes patients in the UK have been treated with the most effective glucose-lowering drug for their condition. Diabetes-related complications not only devastate lives but also cost the UK healthcare system £6.2 billion (around ₹55,800 crore) annually.
New Tool Offers Personalized Treatment
Currently, six major types of glucose-lowering drugs are available in the UK, with Metformin being the most commonly prescribed first-line treatment for type 2 diabetes. However, their effectiveness varies widely, and until now, it has not been possible to determine the best treatment for each patient.
Lead Researcher’s Insights
Lead researcher Dr. John Dennis, Associate Professor at the University of Exeter, said, "For the first time, our model allows people living with type 2 diabetes to quickly identify the best treatment to manage their blood sugar levels, helping reduce their risk of diabetes complications. This offers a major advance over the current approach to choosing diabetes medications."
Model’s Accuracy and Benefits
The tool was developed and tested using data from one million people with type 2 diabetes in the UK, linking general practitioner (GP) and hospital records. Its accuracy was further validated with data from clinical trials.
During the research, modeling showed that starting patients on the drug recommended by the new tool could lead to significant reductions in blood glucose levels after one year—by an average of approximately 5 mmol/mol. Furthermore, according to the study, these improvements could nearly double the time before patients need to start additional diabetes medications. The tool can also predict long-term diabetes complications, including heart attacks, strokes, and kidney disease.
Conclusion
This groundbreaking tool represents a major advancement in the treatment of type 2 diabetes, offering personalized care and potentially saving lives and reducing healthcare costs.
Reference : https://health.economictimes.indiatimes.com/news/health-it/researchers-develop-tool-to-identify-the-most-effective-treatment-for-type-2-diabetics/118629124
![GMC Ongole Announces Recruitment for 2025 – Apply Now for [total_posts] Vacancies](https://theprimenewsnetwork.com/wp-content/uploads/2025/05/GMC-Ongole-Announces-Recruitment-for-2025-–-Apply-Now-for-150x150.png)
